# Maximum Somatic Allele Frequency in Combination With Blood-Based Tumor Mutational Burden to Predict the Efficacy of Atezolizumab in Advanced Non-small Cell Lung Cancer: A Pooled Analysis of the Randomized POPLAR and OAK Studies

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/maximum-somatic-allele-frequency-in-combination-with-blood-based-tumor/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Yutong Chen,Sharvesh Raj Seeruttun,Xiang-yuan Wu,Zixian Wang |
| Citations | 25 |
| DOI | 10.3389/fonc.2019.01432 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://www.frontiersin.org/articles/10.3389/fonc.2019.01432/pdf |
| OpenAlex ID | https://openalex.org/W2996511186 |
| PMID | 31921683 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Yutong Chen](https://scholariq.org/researchers/yutong-chen/)

## Paper journal

- [Frontiers in Oncology](https://scholariq.org/journals/frontiers-in-oncology/)

## Paper primary topic

- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.